ANNEXON, INC. Basic Shares Outstanding (Weighted Average)
ANNEXON, INC. (ANNX) reported Basic Shares Outstanding (Weighted Average) of 201.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- ANNEXON, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 201.00M shares, a 35.52% increase year-over-year.
- ANNEXON, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 194.20M shares, a 31.12% increase year-over-year.
- ANNEXON, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 174.86M shares, a 11.53% increase year-over-year.
- ANNEXON, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 149.12M shares, a 6.57% increase year-over-year.
- ANNEXON, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 155.11M shares, a 12.88% increase from fiscal 2024.
- ANNEXON, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 137.40M shares, a 81.58% increase from fiscal 2023.
- ANNEXON, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 75.67M shares, a 38.41% increase from fiscal 2022.
- ANNEXON, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 54.67M shares, a 42.69% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 201.00M shares 10-Q · filed 2026-08-12 | 197.62M shares 10-Q · filed 2026-08-12 | 190.02M shares derived: average of 3 quarters · filed 2026-08-12 | 179.80M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 194.20M shares 10-Q · filed 2026-05-07 | 184.53M shares derived: average of 2 quarters · filed 2026-05-07 | 172.73M shares derived: average of 3 quarters · filed 2026-05-07 | 166.63M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 174.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 161.99M shares derived: average of 2 quarters · filed 2026-03-30 | 157.43M shares derived: average of 3 quarters · filed 2026-08-12 | 155.11M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 149.12M shares 10-Q · filed 2025-11-10 | 148.72M shares derived: average of 2 quarters · filed 2026-08-12 | 148.52M shares 10-Q · filed 2025-11-10 | 150.58M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 148.32M shares 10-Q · filed 2026-08-12 | 148.22M shares 10-Q · filed 2026-08-12 | 151.07M shares derived: average of 3 quarters · filed 2026-08-12 | 148.29M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 148.11M shares 10-Q · filed 2026-05-07 | 152.44M shares derived: average of 2 quarters · filed 2026-05-07 | 148.27M shares derived: average of 3 quarters · filed 2026-05-07 | 143.74M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 156.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 148.36M shares derived: average of 2 quarters · filed 2026-03-30 | 142.28M shares derived: average of 3 quarters · filed 2026-03-30 | 137.40M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 139.93M shares 10-Q · filed 2025-11-10 | 135.03M shares derived: average of 2 quarters · filed 2025-11-10 | 130.95M shares 10-Q · filed 2025-11-10 | 117.75M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 130.13M shares 10-Q · filed 2025-08-14 | 126.40M shares 10-Q · filed 2025-08-14 | 110.35M shares derived: average of 3 quarters · filed 2025-08-14 | 101.60M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 122.67M shares 10-Q · filed 2025-05-12 | 100.46M shares derived: average of 2 quarters · filed 2025-05-12 | 92.09M shares derived: average of 3 quarters · filed 2025-05-12 | 87.87M shares derived: average of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | 78.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 76.79M shares derived: average of 2 quarters · filed 2025-03-03 | 76.27M shares derived: average of 3 quarters · filed 2025-03-03 | 75.67M shares 10-K · filed 2025-03-03 |
| 2023-09-30 | 75.34M shares 10-Q · filed 2024-11-14 | 75.29M shares derived: average of 2 quarters · filed 2024-11-14 | 74.82M shares 10-Q · filed 2024-11-14 | 74.25M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 75.23M shares 10-Q · filed 2024-08-12 | 74.55M shares 10-Q · filed 2024-08-12 | 73.88M shares derived: average of 3 quarters · filed 2024-08-12 | 72.58M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 73.86M shares 10-Q · filed 2024-05-13 | 73.21M shares derived: average of 2 quarters · filed 2024-05-13 | 71.69M shares derived: average of 3 quarters · filed 2024-05-13 | 63.41M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 72.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 70.61M shares derived: average of 2 quarters · filed 2024-03-26 | 59.93M shares derived: average of 3 quarters · filed 2024-03-26 | 54.67M shares 10-K · filed 2024-03-26 |
| 2022-09-30 | 68.65M shares 10-Q · filed 2023-11-13 | 53.62M shares derived: average of 2 quarters · filed 2023-11-13 | 48.71M shares 10-Q · filed 2023-11-13 | 46.07M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 38.58M shares 10-Q · filed 2023-08-07 | 38.57M shares 10-Q · filed 2023-08-07 | 38.54M shares derived: average of 3 quarters · filed 2023-08-07 | 38.49M shares derived: average of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | 38.56M shares 10-Q · filed 2023-05-08 | 38.52M shares derived: average of 2 quarters · filed 2023-05-08 | 38.46M shares derived: average of 3 quarters · filed 2023-05-08 | 38.42M shares derived: average of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 38.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 38.41M shares derived: average of 2 quarters · filed 2023-03-06 | 38.37M shares derived: average of 3 quarters · filed 2023-03-06 | 38.32M shares 10-K · filed 2023-03-06 |
| 2021-09-30 | 38.34M shares 10-Q · filed 2022-11-03 | 38.31M shares derived: average of 2 quarters · filed 2022-11-03 | 38.26M shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 38.28M shares 10-Q · filed 2022-08-08 | 38.22M shares 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |